根治性前列腺切除术中保留海绵体神经血管束的风险与获益:系统评价与Meta分析
该系统评价与Meta分析检索2000至2014年文献,纳入124项研究共73448例患者,比较保留与不保留神经的根治性前列腺切除术的结局。结果显示保留神经未增加pT2期(RR 0.92)或pT3期(RR 0.83)患者切缘阳性风险,且与3个月和12个月时较低的尿失禁及勃起功能障碍风险相关。作者提醒需谨慎解读,因存在选择偏倚和未校正混杂因素。
要点
- 保留神经未增加pT2期(RR 0.92,95%CI 0.75-1.13)或pT3期(RR 0.83,95%CI 0.71-0.96)切缘阳性风险。
- 保留神经组3个月尿失禁风险RR 0.75(95%CI 0.65-0.85),12个月RR 0.61(95%CI 0.44-0.84)。
- 保留神经组3个月勃起功能障碍风险RR 0.77(95%CI 0.70-0.85),12个月RR 0.53(95%CI 0.39-0.71)。
核心结论
- 在队列研究中,保留神经与更差的肿瘤学结局无关。
- 保留神经与更好的排尿功能和勃起功能相关。
- 鉴于选择偏倚和未校正混杂因素的可能,这些结果应谨慎解读。
研究设计与样本
- 系统检索MEDLINE、Embase和Cochrane Reviews数据库,纳入2000至2014年发表的英文干预性或观察性研究。
- 纳入比较保留神经与不保留神经根治性前列腺切除术临床结局的研究,共124项研究、73448例患者。
- 采用Meta分析计算切缘阳性、勃起功能障碍和尿失禁的合并相对危险度估计值。
- 敏感性分析比较单侧和双侧保留神经与不保留神经组的结局。
主要发现
- 在pT2期患者中,保留神经未增加切缘阳性风险(RR 0.92,95%CI 0.75-1.13)。
- 在pT3期患者中,保留神经未增加切缘阳性风险(RR 0.83,95%CI 0.71-0.96)。
- 保留神经组3个月尿失禁风险较低(RR 0.75,95%CI 0.65-0.85),12个月亦较低(RR 0.61,95%CI 0.44-0.84)。
- 保留神经组3个月勃起功能障碍相对危险度为0.77(95%CI 0.70-0.85),12个月为0.53(95%CI 0.39-0.71)。
- 单侧和双侧保留神经亚组分析显示相似结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出结果应谨慎解读,因存在选择偏倚和未校正混杂因素的可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We summarize published data on associations between cavernous neurovascular bundle preservation (nerve sparing) during prostatectomy and positive surgical margins, erectile function, urinary function and other patient reported outcomes. MATERIALS AND METHODS: A systematic literature search of MEDLINE®, Embase® and Cochrane Reviews databases was performed for interventional or observational studies published between 2000 and 2014. English language articles that compared clinical outcomes of patients undergoing nerve sparing and nonnerve sparing radical prostatectomy were included. Meta-analyses were performed to calculate pooled relative risk estimates for positive surgical margins, erectile dysfunction and urinary incontinence in nerve sparing and nonnerve sparing groups. Sensitivity analyses compared outcomes among unilateral and bilateral nerve sparing vs nonnerve sparing groups. RESULTS: Of the 1,883 articles identified, 124 studies (73,448 patients) were included in the analysis. Nerve sparing did not increase the risk of positive surgical margins in patients with pT2 (RR 0.92, 95% CI 0.75-1.13) or pT3 disease (RR 0.83, 95% CI 0.71-0.96), potentially due to appropriate patient selection. The risk of incontinence was lower in nerve sparing cases (RR 0.75, 95% CI 0.65-0.85 and RR 0.61, 95% CI 0.44-0.84) at 3 and 12 months, respectively. The relative risk of erectile dysfunction with nerve sparing was 0.77 (95% CI 0.70-0.85) at 3 months and 0.53 (95% CI 0.39-0.71) at 12 months. Subgroup analyses of unilateral and bilateral nerve sparing approaches demonstrated similar results. CONCLUSIONS: Among cohort studies nerve sparing was not associated with worse cancer outcomes. Nerve sparing is associated with better urinary and erectile function. These results should be interpreted with caution given the potential for selection bias and unadjusted confounding factors.
引用
- Nguyen LN, Head L, Witiuk K, et al. The Risks and Benefits of Cavernous Neurovascular Bundle Sparing during Radical Prostatectomy: A Systematic Review and Meta-Analysis. J Urol. 2017. PMID: 28286069. doi:10.1016/j.juro.2017.02.3344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。